A standard immunoglobulin preparation produced from bovine colostra shows antibody reactivity and neutralization activity against Shiga-like toxins and EHEC-hemolysin of Escherichia coli O157:H7

Infection

Volumn 24, Issue 5, 1996, Pages 378-383

  Lissner, R ^a   Schmidt, H ^b   Karch, H ^b  

^a BIOTEST AG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOLYSIN; IMMUNOGLOBULIN; LACTOBIN; SHIGA TOXIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CATTLE; COLOSTRUM; CONTROLLED STUDY; CYTOLYSIS; DIARRHEA; ERYTHROCYTE; ESCHERICHIA COLI; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; MONOLAYER CULTURE; NONHUMAN; VERO CELL;

ACYLTRANSFERASES; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; CATTLE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COLOSTRUM; ERYTHROCYTES; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; ESCHERICHIA COLI PROTEINS; FEMALE; HEMOLYSIN PROTEINS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; NEUTRALIZATION TESTS; PREGNANCY; SHIGA-LIKE TOXIN I; SHIGA-LIKE TOXIN II; SHIGELLA; VERO CELLS;

EID: 0029990890     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01716084     Document Type: Article

References (33)

1. Tarr, P. I.: Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin. Infect. Dis. 20 (1995) 1-10.
2. Siegler, R. L., Milligan, M. K., Burningham, T. H., Christofferson, R. D., Chang, S. Y., Jorde, L. B.: Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome. J. Pediatr. 118 (1991) 195-200.
3. Boyce, T. G., Swerdlow, D. L., Griffin, P. M.: Escherichia coli O157:H7 and the hemolytic uremic syndrome. N. Engl. J. Med. 333 (1995) 364-368.
4. Schmidt, H., Beutin, L., Karch, H.: Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli 0157:H7 strain EDL 933. Infect. Immun. 63 (1995) 1055-1061.
5. Bauer, M. E., Welch, R. A.: Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 64 (1996) 167-175.
6. Chapman, P. A., Wright, D. J., Siddons, C. A.: A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from bovine faeces. J. Med. Microbiol. 40 (1994) 424-427.
7. Montenegro, M. A., Bulte, M., Trumpf, T., Aleksic, S., Reuter, G., Bulling, E., Helmuth, R.: Detection and characterization of fecal verotoxin-producing Escherichia coli from healthy cattle. J. Clin. Microbiol. 28 (1990) 1417-1421.
8. Wieler, L. H., Bauerfeind, R., Baljer, G.: Characterization of Shiga-like toxin producing Escherichia coli (SLTEC) isolated from calves with and without diarrhoea. Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis. 276 (1992) 243-253.
9. Pirro, F., Wieler, L. H., Failing, K., Bauerfeind, R., Baljer, G.: Neutralizing antibodies against Shiga-like toxins from Escherichia coli in colostra and sera of cattle. Vet. Microbiol. 43 (1995) 131-141.
10. Brussow, H., Hilpert, H., Walther, I., Sidoti, J., Mietens, C., Bachmann, P.: Bovine milk immunoglobulins for passive immunity to infantile rotavirus gastroenteritis. J. Clin. Microbiol. 25 (1987) 982-986.
11. Tacket, C. O., Losonsky, G., Link, H., Hoang, Y., Guesry, P., Hilpert, H., Levine, M. M.: Protection by milk immunoglobulin concentrate against oral challange with enterotoxigenic Escherichia coli. N. Engl. J. Med. 318 (1988) 1240-1243.
12. Nord, J., Ma, P., DiJohn, D., Tzipori, S., Tacket, C. O.: Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS 4 (1990) 581-584.
13. Gunzer, F., Karch, H.: Expression of A and B subunits of Shiga-like toxin II as fusions with glutathione S-transferase and their potential for use in seroepidemiology. J. Clin. Microbiol. 31 (1993) 2604-2610.
14. Stephan, W., Dichtelmüller, H., Lissner, R.: Antibodies from colostrum in oral immunotherapy. J. Clin. Chem. Clin. Biochem. 28 (1990) 19-23.
15. Schmidt, H., Montag, M., Bockemühl, J., Heesemann, J., Karch, H.: Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples. Infect. Immun. 61 (1993) 534-543.
16. Gentry, M. K., Dalrymple, J. M.: Quantitative microtiter cytotoxicity assay for Shigella toxin. J. Clin. Microbiol. 12 (1980) 361-366.
17. Walterspiel, J. N., Ashkenazi, S., Morrow, A. L., Cleary, T. G.: Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. Infection 20 (1992) 25-29.
18. Proulx, F., Turgeon, J. P., Delage, G., Lafleur, L., Chicoine, L.: Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J. Pediatr. 121 (1992) 299-303.
19. Carter, A. O., Borczyk, A. A., Carlson, J. A., Harvey, B., Hockin, J. C., Karmali, M. A., Krishnan, C., Korn, D. A., Lior, H.: A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home. N. Engl. J. Med. 317 (1987) 1496-1500.
20. Pavia, A. T., Nichols, C. R., Green, D. P., Tauxe, R. V., Mottice, S., Greene, K. D., Wells, J. G., Siegler, R. L., Brewer, E. D., Hannon, D., Blake, P. A.: Hemolyticuremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J. Pediatr. 116 (1990) 544-551.
21. Ostroff, S. M., Kobayashi, J. M., Lewis, J. H.: Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. JAMA 262 (1989) 355-359.
22. Cimolai, N., Carter, J. E., Morrison, B. J., Anderson, J. D.: Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome. J. Pediatr. 116 (1990) 589-592. [Published erratum appeared in J. Pediatr. 116 (1990) 1008.]
23. Armstrong, G. D. Fodor, E., Vanmaele, R.: Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences. J. Infect. Dis. 164 (1991) 1160-1167.
24. Armstrong, G. D., Rowe, P. C., Goodyer, P., Orrbine, E., Klassen, T. P., Wells, G., MacKenzie, A., Lior, H., Blanchard, C., Auclair, F., Thompson, B., Rafter, D. J., McLaine, P. N.: A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome. J. Infect. Dis. 171 (1995) 1042-1045.
25. MacLeod, D. L., Gyles, C. L., Wilcock, B. P.: Reproduction of edema disease of wine with purified Shiga-like toxin-II variant. Vet. Pathol. 28 (1991) 66-73.
26. Richardson, S. E., Rotman, T. A., Jay, V., Smith, C. R., Becker, L. E., Petric, M., Olivieri, N. F., Karmali, M. A.: Experimental verocytotoxemia in rabbits. Infect. Immun. 60 (1992) 4154-4167.
27. Sandvig, K., Olsnes, S., Brown, J. E., Petersen, O. W., van Deurs, B.: Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1. J. Cell Biol. 108 (1989) 1331-1343.
28. Gunzer, F., Böhler, O., Henkel, B., Schwarzkopf, A., Schmidt, H., Karch, H., Lissner, R. : Capability of commercial immunoglobulin preparations to react with and neutralize Shiga-like toxin II. In: Karmali, M. A., Goglio. A. G. (eds.): Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science, Amsterdam 1994, pp. 349-352.
29. Bitzan, M., Klemt, M., Steffens, R., Müller-Wiefel, D. E.: Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls. Infection 21 (1993) 140-145.
30. Scotland, S. M., Rowe, B., Smith, H. R., Willshaw, G. A., Gross, R. J.: Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J. Med. Microbiol. 25 (1988) 237-243.
31. Bitzan, M., Ludwig, K., Klemt, M., König, H., Büren, J., Müller-Wiefel, D. E.: The role of Escherichia coli O157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a central European, multicentre study. Epidemiol. Infect. 110 (1993) 183-196.
32. Ostroff, S. M., Tarr, P. I., Neill, M. A., Lewis, J. H., Hargrett Bean, N., Kobayashi, J. M.: Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J. Infect. Dis. 160 (1989) 994-998.
33. Cohen, A., Madrid Marina, V., Estrov, Z., Freedman, M. H., Lingwood, C. A., Dosch, H. M.: Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism tor the failure of long-lived antibody response to dysenteric disease. Int. Immunol. 2 (1990) 1-8.